AJP - Heart Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 274: H375-H381, 1998;
0363-6135/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pratt, P. F.
Right arrow Articles by Campbell, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pratt, P. F.
Right arrow Articles by Campbell, W. B.
Vol. 274, Issue 1, H375-H381, January 1998

N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor

Phillip F. Pratt, Cecilia J. Hillard, William S. Edgemond, and William B. Campbell

Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226

It has been reported that the endogenous cannabinoid N-arachidonylethanolamide (AEA), commonly referred to as anandamide, has the characteristics of an endothelium-derived hyperpolarizing factor in rat mesenteric artery. We have carried out studies to determine whether AEA affects coronary vascular tone. The vasorelaxant effects of AEA were determined in isolated bovine coronary artery rings precontracted with U-46619 (3 × 10-9 M). AEA decreased isometric tension, producing a maximal relaxation of 51 ± 9% at a concentration of 10-5 M. Endothelium-denuded coronary arteries were not significantly affected by AEA. The CB1 receptor antagonist SR-141716A (10-6 M) failed to reduce the vasodilatory effects of AEA, suggesting that the CB1 receptor is not involved in this action of AEA. Because AEA is rapidly converted to arachidonic acid and ethanolamine in brain and liver by a fatty acid amide hydrolase (FAAH), we hypothesized that the vasodilatory effect of AEA results from its hydrolysis to arachidonic acid followed by enzymatic conversion to vasodilatory eicosanoids. In support of this hypothesis, bovine coronary arteries incubated with [3H]AEA for 30 min hydrolyzed 15% of added substrate; ~9% of the radiolabeled product was free arachidonic acid, and 6% comigrated with the prostaglandins (PGs) and epoxyeicosatrienoic acids (EETs). A similar result was obtained in cultured bovine coronary endothelial cells. Inhibition of the FAAH with diazomethylarachidonyl ketone blocked both the metabolism of [3H]AEA and the relaxations to AEA. Whole vessel and cultured endothelial cells prelabeled with [3H]arachidonic acid synthesized [3H]PGs and [3H]EETs, but not [3H]AEA, in response to A-23187. Furthermore, SR-141716A attenuated A-23187-stimulated release of [3H]arachidonic acid, suggesting that it may have actions other than inhibition of CB1 receptor. These experiments suggest that AEA produces endothelium-dependent vasorelaxation as a result of its catabolism to arachidonic acid followed by conversion to vasodilatory eicosanoids such as prostacyclin or the EETs.

coronary circulation; eicosanoids; endothelial cells; epoxyeicosatrienoic acids; prostaglandins; fatty acid amide hydrolase; endothelium-derived hyperpolarizing factor; N-acylethanolamines


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y.-Y. Yang, H.-C. Lin, Y.-T. Huang, T.-Y. Lee, M.-C. Hou, Y.-W. Wang, F.-Y. Lee, and S.-D. Lee
Roles of anandamide in the hepatic microcirculation in cirrhotic rats
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G328 - G334.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Rademacher, S. Patel, W.-S. V. Ho, A. M. Savoie, N. J. Rusch, K. M. Gauthier, and C. J. Hillard
U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2694 - H2701.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Gauthier, D. V. Baewer, S. Hittner, C. J. Hillard, K. Nithipatikom, D. S. Reddy, J. R. Falck, and W. B. Campbell
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1344 - H1351.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mukhopadhyay, B. M. Chapnick, and A. C. Howlett
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2046 - H2054.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. Vanheel and J. Van de Voorde
Regional Differences in Anandamide- and Methanandamide-Induced Membrane Potential Changes in Rat Mesenteric Arteries
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 322 - 328.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. J. Hillard
Endocannabinoids and Vascular Function
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 27 - 32.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Gebremedhin, A. R. Lange, W. B. Campbell, C. J. Hillard, and D. R. Harder
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current
Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2085 - H2093.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. Fulton and J. Quilley
Evidence against Anandamide as the Hyperpolarizing Factor Mediating the Nitric Oxide-Independent Coronary Vasodilator Effect of Bradykinin in the Rat
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1146 - 1151.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
K. Varga, J. A. Wagner, D. T. Bridgen, and G. Kunos
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
FASEB J, August 1, 1998; 12(11): 1035 - 1044.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mukhopadhyay, B. M. Chapnick, and A. C. Howlett
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2046 - H2054.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online